Advertisement

Thrombose

  • A. Lorentz

Zusammenfassung

Thrombotische Komplikationen stellen in der operativen Medizin ein erhebliches Problem dar, weil sie häufig auftreten und weil sie eine lebensbedrohliche Lungenembolie verursachen können.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aarburg R von, Gruber UF (1978) Prophylaxe postoperativer thromboembolischer Komplikationen bei hüftgelenksnahen Frakturen. Unfallheilkunde 81:475Google Scholar
  2. Arzneimittelkommission der Deutschen Ärzteschaft (1987) Heparin-Dihydergot nicht mehr im Handel. Dtsch Ärzteb 184:1732Google Scholar
  3. Becker J, Schampi B (1973) The incidence of postoperative venous thrombosis of the legs. A comparative study on the prophylactic effect of dextran 70 and electrical calf muscle stimulation. Acta Chir Scand 139:357PubMedGoogle Scholar
  4. Bergquist D (1979) Prophylaxis of postoperative thromboembolic complications with low-dose heparin. Acta Chir Scand 145:7Google Scholar
  5. Bergquist D (1987) Blutungskomplikationen nach niedermolekularem Heparin? Dtsch Med Wochenschr 112:1760Google Scholar
  6. Bergquist D, Hallböök T (1980) Prophylaxis of postoperative venous thrombosis in a controlled trial comparing dextran 70 and low-dose heparin. World J Surg 4:239CrossRefGoogle Scholar
  7. Bergquist D, Efsing HO, Hallböök T, Hedlund T (1979) Thromboembolism after elective and posttraumatic hip surgery. A controlled prophylactic trial with dextran 70 and low-dose heparin. Acta Chir Scand 145:213Google Scholar
  8. Biland L (1983a) Die tiefe Venenthrombose. In: Koller F, Duckert F (Hrsg) Thrombose und Embolie. Schattauer, Stuttgart, S 459–467Google Scholar
  9. Biland L (1983 b) Venöse Thrombosen. Die oberflächliche Thrombophlebitis. In: Koller F, Dukkert F (Hrsg) Thrombose und Embolie. Schattauer, Stuttgart, S 457–459Google Scholar
  10. Bollinger A (1983) Diagnostik: Methoden zum Nachweis von Thrombosen und Embolien. B: Venöse Thrombosen. Ultraschall-Doppler-Methode. In: Koller F, Duckert F (Hrsg) Thrombose und Embolie. Schattauer, Stuttgart, S 143–146Google Scholar
  11. Bonnar J, Walsh J (1972) Prevention of thrombosis after pelvic surgery by British dextran 70. Lancet II:614CrossRefGoogle Scholar
  12. Buttermann G, Theisinger W, Weidenbach A, Hartung R, Welzel D, Pabst HW (1977) Quantitative Bewertung der postoperativen Thromboembolieprophylaxe. Med Klin 72:1624PubMedGoogle Scholar
  13. Cameron JS (1984) Coagulation and thromboembolic complications in the nephrotic syndrome. Adv Nephrol 13:75Google Scholar
  14. Cerrato D, Ariano C, Fiacchino F (1978) Deep vein thrombosis and low-dose heparin prophylaxis in neurosurgical patients. J Neurosurg 49:378PubMedCrossRefGoogle Scholar
  15. Collen D, Lijnen HR, Todd PA, Goa KL (1989) Tissue type plasminogen activator–a review of its pharmacology and therapeutic use as thrombocytic agent. Drugs 38:346PubMedCrossRefGoogle Scholar
  16. Davidson AI, Bruni MEA, Matheson NA (1972) A further trial comparing dextran 70 with warfarin in the prophylaxis of postoperative venous thrombosis. Br J Surg 59:314PubMedCrossRefGoogle Scholar
  17. Dexter L (1969) Natural history of pulmonary embolism. In: Sherry S, Brinkhous KM, Genton E, Stengle J (eds) Thrombosis. National Academy of Sciences, Washington, pp 85Google Scholar
  18. Dexter L, Dalen JE (1978) Pulmonary embolism and acute cor pulmonale. In: Hurst JW (ed) The heart, 4th edn. McGraw-Hill, New York, pp 1472Google Scholar
  19. Duckert F (1983) Antikoagulantien: Heparin. In: Koller F, Duckert F (Hrsg) Thrombose und Embolie. Schattauer, Stuttgart, S 290–305Google Scholar
  20. Duckert F, Marbet GA (1983) Therapie: Therapeutische Fibrinolyse. In: Koller F, Duckert F (Hrsg) Thrombose und Embolie. Schattauer, Stuttgart, S 423–449Google Scholar
  21. Fareed J, Haas S, Enche H, Wolf H, Wetzel D (1991) Randomisierter Vergleich zwischen niedermolekularem Heparin-Sandoz und unfraktioniertem Heparin.Google Scholar
  22. Fitts WT Jr, Erde E, Peskin GW, Front JW (1960) Surgical implications of polycythemia vera. Am Surg 152:548Google Scholar
  23. Fridrich R, Müller-Brand J (1983) Diagnostik: Methoden zum Nachweis venöser Thrombosen. Der Radiofibrinogentest. In: Koller F, Duckert F (Hrsg) Thrombose und Embolie. Schattauer, Stuttgart, S 149–153Google Scholar
  24. Frimann-Dahl J (1935) Postoperative Röntgenuntersuchungen. Acta Chir Scand [Supp] 36:76Google Scholar
  25. Genton E (1983) Medikamentöse Prophylaxe. Plättcheninhibitoren (Plättchenaggregationshemmer). In: Koller F, Duckert F (Hrsg) Thrombose und Embolie, Schattauer, Stuttgart, S 389–390Google Scholar
  26. Goldhaber SZ, Kessler CM, Heit J, Markis J, Sharma GVRK, Dawley D, Nagel JS, Meyerovitz M, Kim D, Vaughan DE, Parker JE, Tumeh SS, Drum D, Loscalz J, Reagan K, Selwyn AP, Anderson J, Braunwald E (1988) A randomized trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet II (8606):293CrossRefGoogle Scholar
  27. Goldhaber SZ (1991) Recent advances in the diagnosis and lytic therapy of pulmonary embolism. Chest 99:173CrossRefGoogle Scholar
  28. Gralnick H, Abrell R (1973) Studies on the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukemia. Br J Haematol 24:89PubMedCrossRefGoogle Scholar
  29. Gruber UF (1981) Dextran. Biochemische Wirkung, ärztliche Überwachung und Laboratoriumskontrolle. In: Marx R, Thies HA (Hrsg) Kontrolle von Antithrombotika. XXIII. Hamburger Symposium über Blutgerinnung. Editiones Roche, Basel Grenzach, S 255–259Google Scholar
  30. Gruber UF (1982) Prevention of fatal postoperative pulmonary embolism by heparin-dihydroergotamine or dextran 70. Br J Surg [Suppl 54] 69:54CrossRefGoogle Scholar
  31. Gruber UF (1983 a) Prophylaxe. Physikalische Einwirkungen. In: Koller F, Duckert F (Hrsg) Thrombose und Embolie, Schattauer, Stuttgart, S 275–281Google Scholar
  32. Gruber UF (1983b) Medikamentöse Prophylaxe. Dextran. In: Koller F, Duckert F (Hrsg) Thrombose und Embolie, Schattauer, Stuttgart, S 355–372Google Scholar
  33. Gruber UF, Duckert F, Fridrich R, Torhorst J, Rem J (1977) Prevention of postoperative thromboembolism by dextran 40, low dose of heparin or xantinol-nicotinate. Lancet I:207CrossRefGoogle Scholar
  34. Gruber UF, Saldeen T, Brokop T et al. (1980) Incidences of fatal postoperative pulmonary embolism after prophylaxis with dextran 70 and low dose heparin: an international multicentre study. Br Med J 280:69PubMedCrossRefGoogle Scholar
  35. Haas S, Haas P, Blümel G (1986) Niedermolekulare Heparine. Eine Übersicht über Wirkungsprofil und bisherige klinische Anwendung. Hämostaseologie 6:180Google Scholar
  36. Haas S, Stemberger A, Fritsche H-M, Wezel D, Wolf H, Lechner F, Blümel G (1987) Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine. Arneimittelforschung 37:839Google Scholar
  37. Harris WH, Salzman EW, Athanasoulis C, Waltman AC, Baum S, DeSanctis RW (1974) Comparison of warfarin, low-molecular-weight dextran, aspirin and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement. J Bone Joint Surg 56:1552PubMedGoogle Scholar
  38. Hedlund PO (1975) Postoperative venous thrombosis in benign prostatic disease. A study of 316 patients with the 125-fibrinogen test. Scand J Urol Nephrol [Suppl] 27:1PubMedGoogle Scholar
  39. Heilmann L, Kruch M, Schindler HE (1989) Thromboseprophylaxe in der Gynäkologie: Doppelblind-Vergleich zwischen niedermolekularem (LMWH) und unfraktioniertem (UFH) Heparin. Geburtshilfe und Frauenheilkd: 769–842Google Scholar
  40. Heinrich F, Klink K (1984) Lungenembolie. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  41. Hirsh JR, Hull D (1978) Comparative value of tests for the diagnosis of venous thrombosis. In: Bernstein EF (ed) Noninvasive diagnostic techniques in vascular disease. Mosby, St. Louis, pp 382Google Scholar
  42. Hirsh J, Ofosu FA, Levine M (1987) The development of low molecular weight heparins for clinical use. In: Verstraete M (ed) Thrombosis and haemostasis. University Press, Leuven, pp 325Google Scholar
  43. Hohl M, Lüscher KP, Gruber UF (1978) Nebenwirkungen bei perioperativer Thromboembolieprophylaxe. Gynäkologe 11:45Google Scholar
  44. Hohl MK (1983) Prophylaxe der tiefen Beinvenenthrombosen und Lungenembolien in der Gynäkologie. In: Koller F, Duckert F (Hrsg) Thrombose und Embolie, Schattauer, Stuttgart, S 506–509Google Scholar
  45. Inman WHW, Vessey MP (1968) Investigation of deaths from pulmonary, coronary and cerebral thrombosis and embolism in women of childbearing age. Br Med J II:193CrossRefGoogle Scholar
  46. Jackman FR, Perry BJ, Siddons H (1978) Deep vein thrombosis after thoracotomy. Thorax 33:61Google Scholar
  47. Joffe SN (1975) Incidence of postoperative deep vein thrombosis in neurosurgical patients. J Neurosurg 42:201PubMedCrossRefGoogle Scholar
  48. Jordan WM (1961) Pulmonary embolism. Lancet 11:1146CrossRefGoogle Scholar
  49. Jung W, Fridrich F, Duckert F, Gruber F (1975) Der Radiofibrinogentest zur Diagnose frischer tiefer Venenthrombosen. Schweiz Med Wochenschr 105:391PubMedGoogle Scholar
  50. Kakkar VV (1978) The current status of low dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism. World J Surg 2:3PubMedCrossRefGoogle Scholar
  51. Kakkar VV, Howe CT, Nicolaides AN, Remey JTG, Clarke MB (1970) Deep vein thrombosis of the leg: is there a high risk group? Am J Surg 120:527PubMedCrossRefGoogle Scholar
  52. Kappert A (1976) Lehrbuch und Atlas der Angiologie. Huber, Bern, S 242–245Google Scholar
  53. Kirchmaier CM (1983) Antithrombin III in patients with proteinuria. In: Wenzel E, Nienhaus K, Rosenberg RD (eds) Antithrombin III – Biochemistry, function, assay and clinical significance. Ann Univ Sarav Med [Suppl] 3:151Google Scholar
  54. Koller F (1983) Prädisposition zu venösen Thrombosen und Lungenembolien. In: Koller F, Duckert F (Hrsg) Thrombose und Embolie, Schattauer, Stuttgart, S 51–83Google Scholar
  55. Koppenhagen K (1991) Klinische Studien zur Thromboseprophylaxe. Unfallchirurgie 17, Sonderheft 1:8–11Google Scholar
  56. Ludwig H (1983) Venenthrombosen in der Schwangerschaft und im Wochenbett. In: Koller F, Duckert F (Hrsg) Thrombose und Embolie, Schattauer, Stuttgart, S 482–501Google Scholar
  57. Mammen EF (1982) Oral contraceptives and blood: a critical review. Am J Obstet Gynecol 142:781PubMedGoogle Scholar
  58. Mammen EF (1987) Gerinnungsstörungen: Eine Herausforderung für den Kliniker. In: Mammen EF (Hrsg) Intensivrnedizin aktuell. Sicherheit in Diagnose und Therapie von Gerinnungsstörungen. Medizinische Verlagsgesellschaft, MarburgGoogle Scholar
  59. Marbert GA (1983) Prädisposition zur Thrombose aufgrund von Laboratoriumsbefunden. In: Koller F, Duckert F (Hrsg) Thrombose und Embolie, Schattauer, Stuttgart, S 85–98Google Scholar
  60. May R (1981) Physikalische Methoden der Thromboseprophylaxe. In: Vinazzer H (Hrsg) Thrombose und Embolie. Springer, Berlin Heidelberg New York, S 213–220Google Scholar
  61. Mayo ME, Halil T, Browse NL (1971) The incidence of deep vein thrombosis after prostatectomy. Br J Urol 43:738PubMedCrossRefGoogle Scholar
  62. McCarthy ST, McQueen J, Johnstone FD et al. (1974) A comparison oflow dose subcutaneous heparin and intravenous dextran 70 in the prophylaxis of deep venous thrombosis after gynaecological surgery. J Obstet Gynaecol Br Commonw 81:486PubMedCrossRefGoogle Scholar
  63. McCarthy ST, Tanner JJ, Robertson D et al. (1977) Low dose heparin as a prophylaxis against deep vein thrombosis after acute stroke. Lancet II:800CrossRefGoogle Scholar
  64. McKenzie PJ, Loach AB (1986) Local anaesthesia for orthopaedic surgery. Br J Anaesth 58:779PubMedCrossRefGoogle Scholar
  65. Modig J, Kalstrom G, Maripun E, Sahlstedt B (1980) Thromboembolism after total hip replacement: role of epidural and general anesthesia. Anesth Analg 62:174Google Scholar
  66. Modig J, Borg T, Bagge L, Saldeen T (1983) Role of extradural and of general anesthesia in fibrinolysis and coagulation after total hip replacement. Br J Anaesth 55:625PubMedCrossRefGoogle Scholar
  67. Nicolaides AN, Field ES, Kakkar VV, Yates-Bell AJ, Taylor S, Clarke MB (1972) Prostatectomy and deep vein thrombosis. Br J Surg 59:487PubMedCrossRefGoogle Scholar
  68. Partsch H (1978) Doppler-Ultraschall und Isotopen-Phlebographie zur praktischen Diagnostik von venösen Beckenabflußhindernissen. In: Kriessmann A, Bollinger A (Hrsg) UltraschallDoppler- Diagnostik. Thieme, Stuttgart, S 161–166Google Scholar
  69. Pearson TC, Wetherley-Mein G (1978) Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia. Lancet II:1219CrossRefGoogle Scholar
  70. Pezzuoli G, Neri Seneri GG, Coggi G et al. (1987) Step-multicenter double-blind controlled clinical trial on the prevention of fatal pulmonary embolism with the low molecular weight heparin Cy 216 (Abstr.). In: Breddin K (ed) Fraxiparine. Analytical and structural data, pharmacology, clinical trials. Schattauer, Stuttgart New York, pp 12Google Scholar
  71. Pineo GF, Brian MC, Gallus AS et al. (1974) Tumors, mucus production and hypercoagulability. Ann NY Acad Sci 230:262PubMedCrossRefGoogle Scholar
  72. Roessle R (1937) tiber die Bedeutung und Entstehung der Wadenvenenthrombosen. Virchows Arch 300:180CrossRefGoogle Scholar
  73. Sagar S, Stamatakis JD, Higgins AF, Nair D, Maffei FH, Thomas DP, Kakkar VV (1976a) Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total hip replacement. Lancet I:1151CrossRefGoogle Scholar
  74. Sagar S, Stamatakis JD, Thomas DP, Kakkar VV (1976b) Oral contraceptives, antithrombinIII- activity and postoperative deep-vein thrombosis. Lancet 1:509PubMedCrossRefGoogle Scholar
  75. Sasahara AA, Koppenhagen K, Häring R, Welzel D, Wolf H (1986) Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis. Br J Surg 73:697PubMedCrossRefGoogle Scholar
  76. Schaub N, Duckert F, Friedrich R, Gruber UF (1975) Häufigkeit postoperativer tiefer Venenthrombosen bei Patienten der Allgemeinen Chirurgie und Urologie. Langenbeck’s Arch Chir 340:23CrossRefGoogle Scholar
  77. Schöndorf TH, Weber U (1980) Prevention of deep vein thrombosis in orthopedic surgery with the combination oflow dose heparin plus either dihydroergotamine or dextran. Scand J Haematol [Suppl 36] 25:126Google Scholar
  78. Schrader J, Köstering H, Kramer P, Scheler F (1982) Antithrombin III – Substitution bei dialysepflichtiger Niereninsuffizienz. Dtsch Med Wochenschr 107:1847PubMedCrossRefGoogle Scholar
  79. Schramm W (1984) Thromboembolie – Die klinische Bedeutung des Antithrombin III. Internist (Berlin) 28:88Google Scholar
  80. Seglias J, Gruber UF (1979) Dosage in low-dose heparin prophylaxis. Haemostasis 8:361PubMedGoogle Scholar
  81. Sevitt S (1962) Venous thrombosis and pulmonary embolism. Their prevention by oral anticoagulants. Am J Med 33:703PubMedCrossRefGoogle Scholar
  82. Sevitt S (1969) Venous thrombosis in injured patients. In: Sherry S, Brinkhous KM, Genton E, Stengle JM (eds) Thrombosis. National Academiy of Sciences, WashingtonGoogle Scholar
  83. Sevitt S, Gallagher NG (1959) Prevention of venous thrombosis and pulmonary embolism in injured patients. Lancet II:981CrossRefGoogle Scholar
  84. Sise HS, Booth J, O’Leary R, O’Riordan C, Banks H (1972) Double blind evaluation of dextran 40 for prevention of venous thrombosis in hip fracture using 125-I-fibrinogen test. Circulation 46:222Google Scholar
  85. Thaler E, Lechner K (1981) Antithrombin III deficiency and thromboembolism. Clin Haematol 10:369PubMedGoogle Scholar
  86. Thies HA, Oppelt W (1961) Zur Strömungsgeschwindigkeit des Blutes vor und nach Operationen. Chirurg 32:135PubMedGoogle Scholar
  87. Thorburn J, Louden JR, Vallance R (1980) Spinal and general anesthesia in total hip replacement: frequency of deep vein thrombosis. Br J Anaesth 52:1117PubMedCrossRefGoogle Scholar
  88. Tilsner V (1985) Antithrombin III. Bedeutung, Diagnostik und Therapie. Med Welt 36:534Google Scholar
  89. Vinazzer H (1981) Klinische Diagnostik venöser Thrombosen und ihre Wertigkeit. In: Vinazzer H (Hrsg) Thrombose und Embolie. Springer, Berlin Heidelberg New York, S 78–81Google Scholar
  90. Voigt J, Hamelmann H, Hedderich J, Seifert J, Buchhammer T, Köhler A (1986) Wirksamkeit und unerwünschte Wirkungen von niedermolekularem Heparin-Dihydergotamin zur Thromboembolieprophylaxe in der Abdominalchirurgie. Zentralbl Chir 111:1286Google Scholar
  91. Weber W, Nagel G (1976) Blutgerinnungsstörungen als paraneoplastisches Syndrom. In: Neuhaus K, Duckert F (Hrsg) Blutgerinnung und Antikoagulation. Schattauer, Stuttgart, S 41–48Google Scholar
  92. Werthemann A, Rutishauser G (1954) Zur pathologischen Anatomie der Thrombose. In: Koller T, Merz WR (Hrsg) Thrombose und Embolie. Schwabe, Basel, S 527–542Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • A. Lorentz

There are no affiliations available

Personalised recommendations